
    
      This study is designed to investigate the efficacy, safety, tolerability of a new drug,
      MEDI4736 (Durvalumab), in patients with Locally Advanced or Metastatic Non Small Cell Lung
      Cancer. MEDI4736 will be investigated in patients who have received at least two prior
      treatment regimens including one platinum-based chemotherapy
    
  